Pneumococcal vaccines for allergic airways diseases

Expert Opinion on Biological Therapy

Volumn 9, Issue 5, 2009, Pages 621-629

  Thorburn, Alison N ^a   Hansbro, Philip M ^a   Gibson, Peter G ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Allergy; Asthma; Eosinophil; Immunoregulatory; Infection; Streptococcus pneumoniae; T regulatory cell; Vaccine

Indexed keywords

BCG VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ALLERGIC ASTHMA; CLINICAL TRIAL; DISEASE COURSE; EOSINOPHILIA; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOTHERAPY; NONHUMAN; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PREVALENCE; REGULATORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL;

STREPTOCOCCUS PNEUMONIAE;

EID: 67649114590     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590902916999     Document Type: Review

References (72)

1. Patel S, Jarvelin M-R, Little M. Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environmental Health 2008;7:57. Published online 10 November 2008, doi:10.1186/1476-069X-7-57
2. Peat JK, Van Den Berg RH, Green WF, et al. Changing prevalence of asthma in Australian children. BMJ 1994;308:1591-1596 (Pubitemid 24181866)
3. Toelle BG, Ng K, Belousova E, et al. Prevalence of asthma and allergy in schoolchildren in Belmont, Australia: three cross sectional surveys over 20 years. BMJ 2004;328:386-387
4. Gibson PG, Henry RL, Shah S, et al. Migration to a western country increases asthma symptoms but not eosinophilic airway inflammation. Pediatr Pulmonol 2003;36:209-215 (Pubitemid 37055968)
5. Jones PD, Gibson PG, Henry RL. The prevalence of asthma appears to be inversely related to the incidence of typhoid and tuberculosis: hypothesis to explain the variation in asthma prevalence around the world. Med Hypotheses 2000;55:40-42 (Pubitemid 30612082)
6. Wickens K, Pearce N, Crane J, et al. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy 1999;29:766-771 (Pubitemid 29268465)
7. Alm B, Erdes L, Mollborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697-702
8. Verhulst SL, Vael C, Beunckens C, et al. A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J Asthma 2008;45:828-832
9. Wickens K, Ingham T, Epton M, et al. The association of early life exposure to antibiotics and the development of asthma, eczema and atopy in a birth cohort: confounding or causality? Clin Exp Allergy 2008;38:1318-1324
10. Miyake Y, Arakawa M, Tanaka K, et al. Tuberculin reactivity and allergic disorders in schoolchildren, Okinawa, Japan. Clin Exp Allergy 2008;38:486-492 (Pubitemid 351208074)
11. Linehan MF, Frank TL, Hazell ML, et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol 2007;119:1079-1085
12. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;107:531-534 (Pubitemid 32210036)
13. Alm JS, Lilja G, Pershagen G, et al. Early BCG vaccination and development of atopy. Lancet 1997;350:400-403 (Pubitemid 27331234)
14. Strannegard IL, Larsson LO, Wennergren G, et al. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-254 (Pubitemid 28125928)
15. Aaby P, Shaheen SO, Heyes CB, et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000;30:644-650 (Pubitemid 30305626)
16. Shirtcliffe PM, Easthope SE, Cheng S, et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med 2001;163:1410-1414 (Pubitemid 32506608)
17. Shirtcliffe PM, Easthope SE, Weatherall M, et al. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 2004;34:207-212 (Pubitemid 38315256)
18. Hirose I, Tanaka H, Takahashi G, et al. Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice. Int Arch Allergy Immunol 2008;147:6-16
19. Gauvreau GM, Hessel EM, Boulet L-P, et al. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 2006;174:15-20 (Pubitemid 43955239)
20. Schwartz DA, Quinn TJ, Thorne PS, et al. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 1997;100:68-73 (Pubitemid 27311244)
21. Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007;357:1487-1495 (Pubitemid 47572634)
22. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005;352:2082-2090 (Pubitemid 40667531)
23. Flory J, Joffe M, Fishman N, et al. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect 2008;1-10
24. Almirall J, Bolibar I, Serra-Prat M, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 2008;31:1274-1284
25. Ansaldi F, Turello V, Lai P, et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res 2005;33:490-500 (Pubitemid 41388386)
26. Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev 2002;CD002165, doi: 10.1002/14651858.CD002165 •• Cochrane review of the use of Pneumococcal vaccines for asthma. Shows that vaccines may be protective but suggests this is due to the prevention of Spn-induced exacerbations rather than immune modulation.
27. Schuller D. Prophylaxis of otitis media in asthmatic children. Pediatr Infect Dis 1983;2:280-283 •• This paper shows that Spn vaccination to prevent otitis media is associated with a 56% reduction in acute asthma attacks.
28. Spink W. Effects of vaccines and bacterial and parasitic infections on eosinophilia in trichinous animals. Arch Intern Med 1934;54:805-817
29. Morgan J, Beeson P. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol 1971;52:214-222
30. Bass DA. Behaviour of eosinophil leukocytes in acute inflammation. Lack of dependence on adrenal function. J Clin Invest 1975;55:1229-1236 • This paper describes eosinophilia during trichinosis being reversed by Spn infection. (Pubitemid 8036484)
31. Bass D. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 1975;56:870-879
32. Dietert RR, Zelikoff JT. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Dev Reprod Toxicol 2008;83:547-560
33. Afshar R, Medoff B, Luster A. Allergic asthma: a tale of many T cells. Clin Exp Allergy 2008;38:1847-1857
34. Fanta CH. Asthma. N Engl J Med 2009;360:1002-1014
35. Abdulamir AS, Hafidh RR, Abubakar F, et al. Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC Immunology 2008;9:73. Published online 16 December 2008, doi:10.1186/1471-2172-9-73
36. Trautmann A, Kruger K, Akdis M, et al. Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol 2005;138:142-150 (Pubitemid 41540671)
37. Lee JH, Yu HH, Wang LC, et al. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007;148:53-63 (Pubitemid 46364997)
38. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575 •• This paper highlights the interplay and differences in Tregs between healthy and allergic individuals. (Pubitemid 38780411)
39. Ling E, Smith T, Nguyen X, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615 (Pubitemid 38264178)
40. Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-1433 (Pubitemid 39575901)
41. Shi HZ, Li S, Xie ZF, et al. Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 2004;113:172-178 (Pubitemid 39296850)
42. Bellinghausen I, Klostermann B, Knop J, et al. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003;111:862-868
43. Grindebacke H, Wing K, Andersson A, et al. Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34:1364-1372 (Pubitemid 39233690)
44. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003;15:430-435 (Pubitemid 36774255)
45. Cottrez F, Hurst SD, Coffman RL, et al. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-53 • In this paper Treg clones are demonstrated to inhibit Th2 responses.
46. Stock P, Akbari O, Dekruyff RH, et al. Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 2005;175:7380-7387 (Pubitemid 41713435)
47. Zhang Q, Fen-hong Q, Hua L, et al. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chinese Medical Journal 2008;121:205-212 (Pubitemid 351234586)
48. Kearley J, Barker JE, Robinson DS, et al. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005;202:1539-1547 •• The first research, to our knowledge, to show inhibition of airway dysfunction by transfer of Tregs. (Pubitemid 41746600)
49. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111:1255-1261 •• This paper describes successful antigen-specific immunotherapy through the induction of Tregs.
50. Jutel M, Akdis M, Budak F, et al. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214 (Pubitemid 36609138)
51. Hadley JS, Wang JE, Foster SJ, et al. Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect Immun 2005;73:7613-7619
52. Schroder NW, Morath S, Alexander C, et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003;278:15587-15594 (Pubitemid 36799667)
53. Dziarski R, Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun 2005;73:5212-5216 (Pubitemid 41105684)
54. Kadioglu A, Andrew PW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004;25:143-149 (Pubitemid 38249488)
55. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-1278 (Pubitemid 26393906)
56. Malley R, Stack AM, Ferretti ML, et al. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. J Infect Dis 1998;178:878-882 (Pubitemid 28397243)
57. Anderson P, Pichichero MEINSEL. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. J Pediatr 1985;107:346-351 (Pubitemid 15240785)
58. Ahman H, Kayhty H, Lehtonen H, et al. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998;17:211-216 (Pubitemid 28146062)
59. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-476 (Pubitemid 39370503)
60. Kadioglu A, Coward W, Colston MJ, et al. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun 2004;72:2689-2697 •• This research showed that Treg cells are induced by Spn to a greater extent than by other Gram-positive bacteria. (Pubitemid 38542395)
61. Akbari O, Stock P, Dekruyff RH, et al. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003;15:627-633 • This paper and [68] describe of chronic models of AAD that are representative of human asthma. (Pubitemid 37434069)
62. Fattouh R, Midence NG, Arias K, et al. Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008;177:593-603
63. Zuany-Amorim C, Sawicka E, Manlius C, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8:625-629 (Pubitemid 34633442)
64. Siegle JS, Hansbro N, Herbert C, et al. Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol 2006;35:565-570 (Pubitemid 44706429)
65. Ito K, Herbert C, Siegle JS, et al. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol 2008;39:543-550
66. Horvat JC, Beagley KW, Wade MA, et al. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 2007;176:556-564 • This research uses a model of acute phases of asthma. (Pubitemid 47403273)
67. Preston JA, Essilfie A-T, Horvat JC, et al. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 2007;25:8154-8162 •• The first publication, to our knowledge, to show that Spn exposure can suppress AAD in mouse models. (Pubitemid 350054909)
68. Gingles NA, Alexander JE, Kadioglu A, et al. Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect Immun 2001;69:426-434 • This paper and [61] describe of chronic models of AAD that are representative of human asthma. (Pubitemid 32038342)
69. Preston JA, Beagley KW, Gibson PG, et al. Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia. Eur Respir J 2004;23:224-231 • A mouse model of non-fatal Spn respiratory infection is described. (Pubitemid 38195507)
70. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101 (Pubitemid 43827959)
71. Goldblatt D. Conjugate vaccines. Clin Exp Immunol 2000;119:1-3 (Pubitemid 30064584)
72. Meltzer U, Goldblatt D. Pneumococcal polysaccharides interact with human dendritic cells. Infect Immun 2006;74:1890-1895 (Pubitemid 43346826)